Experienced in Hypomelanotic Disorder

Dr. Mitchel P. Goldman

Dermatology
9339 Genesee Ave, 300, 
San Diego, CA 
Experienced in Hypomelanotic Disorder
9339 Genesee Ave, 300, 
San Diego, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mitchel Goldman is a Dermatologist in San Diego, California. Dr. Goldman is rated as an Experienced provider by MediFind in the treatment of Hypomelanotic Disorder. His top areas of expertise are Melasma, Telangiectasia, Pigmented Purpuric Dermatosis, and Bowen's Disease.

His clinical research consists of co-authoring 176 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles and participated in 1 clinical trial in the study of Hypomelanotic Disorder.

Specialties
Dermatology
Licenses
Procedural Dermatology in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

9339 Genesee Ave, 300, San Diego, CA 92121

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Intradermally Administered AIV001 in Subjects With Papulopustular Rosacea
A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Intradermally Administered AIV001 in Subjects With Papulopustular Rosacea
Enrollment Status: Withdrawn
Publish Date: December 17, 2024
Intervention Type: Drug
Study Drugs: AIV001, Vehicle
Study Phase: Phase 1/Phase 2
A Prospective Blinded Within-Subject Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions
A Prospective Blinded Within-Subject Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions
Enrollment Status: Completed
Publish Date: May 24, 2024
Intervention Type: Device
Study Phase: Not Applicable
Open-Label, Intra Subject, Dose Escalation (Part 1) Followed by Randomized, Double Blind, Placebo Controlled (Part 2) Trial of Topical VT30 in Pts With Venous, Lymphatic or Mixed Malformations Associated With PIK3CA or TEK Genetic Mutations
Open-Label, Intra Subject, Dose Escalation (Part 1) Followed by Randomized, Double Blind, Placebo Controlled (Part 2) Trial of Topical VT30 in Pts With Venous, Lymphatic or Mixed Malformations Associated With PIK3CA or TEK Genetic Mutations
Enrollment Status: Terminated
Publish Date: August 04, 2022
Intervention Type: Drug
Study Drug: VT30
Study Phase: Phase 1/Phase 2
A Prospective, Single-center, Investigator-blinded Trial to Evaluate the Safety and Efficacy of Secret Micro-Needle Fractional RF System® for the Treatment of Facial Wrinkles
A Prospective, Single-center, Investigator-blinded Trial to Evaluate the Safety and Efficacy of Secret Micro-Needle Fractional RF System® for the Treatment of Facial Wrinkles
Enrollment Status: Unknown
Publish Date: May 10, 2019
Intervention Type: Device
Study Phase: Not Applicable
A Split-body, Double-blinded, Placebo-controlled Trial of Stratacel® Wound Dressing After Laser Treatment of Striae Alba
A Split-body, Double-blinded, Placebo-controlled Trial of Stratacel® Wound Dressing After Laser Treatment of Striae Alba
Enrollment Status: Unknown
Publish Date: May 10, 2019
Intervention Type: Other, Device
Study Phase: Not Applicable
A Randomized, Double-blind, Dose-ranging Trial of Subcutaneous Sodium Deoxycholate Injections With or Without Low Dose Triamcinolone and Low Dose Lidocaine for Reduction of Submental Fat With Reduction of Pain and Swelling
A Randomized, Double-blind, Dose-ranging Trial of Subcutaneous Sodium Deoxycholate Injections With or Without Low Dose Triamcinolone and Low Dose Lidocaine for Reduction of Submental Fat With Reduction of Pain and Swelling
Enrollment Status: Completed
Publish Date: May 09, 2019
Intervention Type: Drug, Combination product
Study Phase: Phase 4
Follow-up of Patients Treated in VeClose Study (Five Years)
Follow-up of Patients Treated in VeClose Study (Five Years)
Enrollment Status: Completed
Publish Date: April 12, 2019
Intervention Type: Device
Evaluation of VeinViewer in Cosmetic Dermatology
Evaluation of VeinViewer in Cosmetic Dermatology
Enrollment Status: Completed
Publish Date: October 17, 2018
Intervention Type: Device
Study Phase: Not Applicable
TR-987 vs. Placebo Following Fractionated CO2 Laser Resurfacing of the Chest
TR-987 vs. Placebo Following Fractionated CO2 Laser Resurfacing of the Chest
Enrollment Status: Completed
Publish Date: March 01, 2017
Intervention Type: Other
Study Phase: Not Applicable
A Randomized, Double-blind, Placebo-controlled, Prospective Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy
A Randomized, Double-blind, Placebo-controlled, Prospective Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy
Enrollment Status: Completed
Publish Date: March 01, 2017
Intervention Type: Drug, Other
Study Phase: Not Applicable
View 9 Less Clinical Trials

176 Total Publications

A Single-Center, Blinded, Split-Body, Randomized Clinical Trial of High-Intensity, Parallel Ultrasound Beams Versus Microfocused Ultrasound With Visualization for the Treatment of Upper Inner Arm Skin Laxity.
A Single-Center, Blinded, Split-Body, Randomized Clinical Trial of High-Intensity, Parallel Ultrasound Beams Versus Microfocused Ultrasound With Visualization for the Treatment of Upper Inner Arm Skin Laxity.
Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Published: September 30, 2025
Similar Doctors
Distinguished in Hypomelanotic Disorder
Dr. Deborah H. Atkin
Dermatology
Distinguished in Hypomelanotic Disorder
Dr. Deborah H. Atkin
Dermatology

J Robert West MD Inc

12865 Pointe Del Mar Way, Suite 160, 
Del Mar, CA 
 (4.3 miles away)
858-350-7546
Languages Spoken:
English
See accepted insurances

Deborah Atkin is a Dermatologist in Del Mar, California. Dr. Atkin is rated as a Distinguished provider by MediFind in the treatment of Hypomelanotic Disorder. Her top areas of expertise are Griscelli Syndrome, Dyschromatosis Universalis Hereditaria, Dyschromatosis Symmetrica Hereditaria, and Hypomelanotic Disorder.

Distinguished in Hypomelanotic Disorder
Dr. Antoanella Calame
Dermatology
Distinguished in Hypomelanotic Disorder
Dr. Antoanella Calame
Dermatology

Compass Dermatopathology Inc

6605 Nancy Ridge Dr, 
San Diego, CA 
 (2.1 miles away)
858-750-2983
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Antoanella Calame is a Dermatologist in San Diego, California. Dr. Calame is rated as a Distinguished provider by MediFind in the treatment of Hypomelanotic Disorder. Her top areas of expertise are Seborrheic Keratosis, Warts, Acrospiroma, Syringocystadenoma Papilliferum, and Tissue Biopsy. Dr. Calame is currently accepting new patients.

Philip R. Cohen
Distinguished in Hypomelanotic Disorder
Dr. Philip R. Cohen
Dermatology
Distinguished in Hypomelanotic Disorder
Dr. Philip R. Cohen
Dermatology
655 Euclid Ave Ste 401, 
National City, CA 
 (15.8 miles away)
619-267-8303
Languages Spoken:
English
See accepted insurances

Philip Cohen is a Dermatologist in National City, California. Dr. Cohen is rated as an Elite provider by MediFind in the treatment of Hypomelanotic Disorder. His top areas of expertise are Seborrheic Keratosis, Pyogenic Granuloma, Basal Cell Skin Cancer, Tissue Biopsy, and Laminectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Goldman's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile